BioAtla BCAB Income Statement (2020-2026)

NASDAQ BCAB
$3.18 -0.05 (-1.55%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
0.70M0.72M0.72M0.72M0.73M0.93M0.95M0.96M0.96M0.96M0.96M0.97M0.97M1.16M1.17M1.17M1.18M1.27M1.66M1.66M
Revenue & cost
Revenue (Quarter)
11.00M2.00M6.50M
Operating items
Research & Development (Quarter)
16.55M16.45M16.92M20.71M19.84M21.87M21.70M30.96M28.40M22.67M18.85M16.20M16.39M11.65M12.36M13.68M9.54M8.00M4.58M3.34M
Selling, General & Administrative (Quarter)
7.14M7.04M7.42M8.34M6.34M6.69M7.23M6.24M6.62M5.86M5.61M5.77M5.88M4.59M5.26M4.96M4.25M3.26M4.73M2.93M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
23.70M23.49M24.35M29.05M26.18M28.56M28.93M37.20M35.02M28.54M24.46M21.97M22.27M16.24M17.61M18.65M13.79M11.26M9.31M6.27M
Operating Income (Quarter)
-23.70M-23.49M-24.35M-29.05M-26.18M-28.56M-28.93M-37.20M-35.02M-28.54M-24.46M-21.97M-11.27M-16.24M-17.61M-18.65M-13.79M-9.26M-9.31M0.23M
EBIT (Quarter)
-23.70M-23.49M-24.35M-29.05M-26.18M-28.56M-28.93M-37.20M-35.02M-28.54M-24.46M-21.97M-11.27M-16.24M-17.61M-18.65M-13.79M-9.26M-9.31M0.23M
Non-operating items
Interest & Investment Income (Quarter)
0.08M0.10M0.09M0.15M0.37M1.05M1.48M1.46M1.73M1.64M1.22M0.90M0.69M0.55M0.40M0.23M0.13M0.07M0.04M0.02M
Other Non Operating Income (Quarter)
0.77M0.09M0.15M0.40M1.02M1.47M1.45M1.70M1.61M1.22M0.90M0.68M1.36M2.28M-0.06M-1.99M-0.53M2.96M0.23M
Non Operating Income (Quarter)
-0.00M0.00M0.01M0.00M0.03M-0.03M-0.01M-0.01M-0.04M-0.03M-0.01M-0.00M
Net income details
EBT (Quarter)
-23.99M-24.76M-24.64M-91.08M-2759.50M-27.91M-27.86M-133.99M-34.13M-27.17M-472.87M-22.77M-11.85M-15.70M-17.50M-26.27M-15.28M-9.18M-9.29M-6.88M
Profit After Tax (Quarter)
-22.93M-23.39M-24.25M-28.91M-25.78M-27.54M-27.46M-35.75M-33.33M-26.93M-23.23M-21.07M-10.59M-14.88M-15.33M-18.71M-15.78M-9.78M-6.34M0.45M
Income from Continuing Operations (Quarter)
-23.99M-24.76M-24.64M-91.08M-2759.50M-27.91M-27.86M-133.99M-34.13M-27.17M-472.87M-22.77M-11.85M-15.70M-17.50M-26.27M-15.28M-9.18M-9.29M-6.88M
Consolidated Net Income (Quarter)
-23.99M-24.76M-24.64M-91.08M-2759.50M-27.91M-27.86M-133.99M-34.13M-27.17M-472.87M-22.77M-11.85M-15.70M-17.50M-26.27M-15.28M-9.18M-9.29M-6.88M
Income towards Parent Company (Quarter)
-23.99M-24.76M-24.64M-91.08M-2759.50M-27.91M-27.86M-133.99M-34.13M-27.17M-472.87M-22.77M-11.85M-15.70M-17.50M-26.27M-15.28M-9.18M-9.29M-6.88M
Net Income towards Common Stockholders (Quarter)
-22.93M-24.76M-24.64M-91.08M-2759.50M-27.91M-27.86M-133.99M-34.13M-27.17M-472.87M-22.77M-11.85M-15.70M-17.50M-26.27M-15.28M-9.18M-9.29M-6.88M
Additional items
EPS (Basic) (Quarter)
-33.81-35.82-33.01-121.69-0.00M-35.85-29.27-140.43-35.68-28.44-491.68-23.61-12.26-16.16-15.02-22.45-13.00-7.80-6.19-4.15
EPS (Diluted) (Quarter)
-33.81-35.82-33.01-121.69-0.00M-35.85-29.27-140.43-35.68-28.44-491.68-23.61-12.26-16.16-15.02-22.45-13.00-7.80-6.19-4.14
Shares Outstanding (Quarter)
0.68M0.69M0.75M0.75M0.75M0.78M0.95M0.95M0.96M0.96M0.96M0.96M0.97M0.97M1.16M1.17M1.17M1.18M1.50M1.66M
Shares Outstanding (Diluted) (Quarter)
0.68M0.69M0.75M0.75M0.75M0.78M0.95M0.95M0.96M0.96M0.96M0.96M0.97M0.97M1.16M1.17M1.17M1.18M1.50M1.66M
EBITDA (Quarter)
-23.70M-23.49M-24.35M-29.05M-26.18M-28.56M-28.93M-37.20M-35.02M-28.54M-24.46M-21.97M-11.27M-16.24M-17.61M-18.65M-13.79M-9.26M-9.31M0.23M
Interest Expenses (Quarter)
0.37M1.37M0.38M62.17M2,733.69M0.40M0.41M98.25M0.84M0.27M449.64M1.69M1.27M0.01M0.29M7.86M1.62M0.02M7.13M